Organon

Sun Pharma plans $1 bn local debt sale for loan takeout

Healthcare

29 September, 2026

Sun Pharma plans $1 bn local debt sale for loan takeout

India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-......

Premium

Healthcare

11 June, 2026

Pharma firm Leeford Healthcare plans maiden private equity round

Pharmaceutical company Leeford Healthcare Ltd is planning to sell a minority stake in its maiden institutional private ......

Premium

Healthcare

09 June, 2026

ChrysCap, two other PE firms vying for stake in domestic formulations maker

A clutch of private equity investors including ChrysCapital, Malaysia's Creador and Bahrain-headquartered Investcorp......

Premium

Healthcare

03 June, 2026

PE-backed drugmaker Brinton eyes fresh fundraise, hires banker

Pune-based drugmaker Brinton Pharmaceuticals Ltd is planning a fresh equity round of funding after a hiatus of nearly ......

Premium

Healthcare

06 May, 2026

PE firms circle Tata Capital Healthcare-backed Linux Laboratories

Linux Laboratories Pvt Ltd, a pharmaceutical company focussed on central nervous system (CNS) therapies, is in talks ......

Premium

Finance

01 May, 2026

Deals Digest: PE-VC deal value recovers; Sun Pharma's Organon buy boosts M&As

Private equity (PE) and venture capital (VC) deal value recovered sharply this week, even as activity cooled. Meanwhile......

Healthcare

27 April, 2026

Sun Pharma to acquire US-listed Organon in $11.75-bn deal

Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.......

Premium

General

24 April, 2026

Grapevine: TPG, GIC, CPPIB, Sun Pharma, Jubilant, others in news

Sun Pharma has tabled a new binding offer for US-based Organon, marking its biggest global bet yet, while institutional ......

Premium

General

10 April, 2026

Grapevine: upGrad, Sun Pharma, Blume, Qualcomm Ventures, others in news

Sun Pharmaceutical Industries is a step closer to buying US drugmaker Organon while edtech startup upGrad is witnessing ......

Premium

General

19 January, 2026

Grapevine: Sun Pharma, Organon, Blackstone, Neysa, Medsource Ozone in news

Sun Pharmaceutical Industries is weighing a potential acquisition of US‑based women’s health and biosimilars player......